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Cutaneous melanoma (CM) is responsible for 75% of deaths from malignant skin cancer. The incidence of CM in the southern
region of Brazil, particularly in the western region of Santa Catarina, is possibly higher than estimated. In this study, the clinical
and epidemiological proﬁle of patients with CM treated in the western region of Santa Catarina was examined. A cross-sectional
study was performed with patients diagnosed with CM from January 2002 to December 2009, from 78 counties of the western
region of the state of Santa Catarina. Data were collected using a protocol adapted from the Brazilian Melanoma Group and 503
patients were evaluated. The incidence and prevalence of CM found in this region are much higher than those found elsewhere in
the country. This fact is most likely due to the phenotypic characteristics of the population and the high incidence of UV radiation
in this region due to its location in southern Brazil, as is the case in the countries of Oceania.
1.Introduction
Among skin cancers, cutaneous melanoma (CM) is the least
frequent. However, it presents a higher mortality rate, mostly
due to its ability to invade and spread through diﬀerent
tissues [1]. Nevertheless, when detected in its early stages, it
has a high cure rate [2].
CM occurs predominantly in white populations [1]. The
CMincidenceratesareparticularlyhighinNorthernEurope,
NorthAmerica,andAustraliaandlowamongtheindigenous
population of Africa, Asia, Latin America, and southern
Europe [3]. In New Zealand and Australia, in 2002, a global
analysisshowedanincidenceofCMamongmenof37.7cases
per 100 000 inhabitants and 29.4 among women [4].
Queensland, Australia, is regarded as having the highest
incidence of melanoma worldwide: 51 per 100 000 in 2002
[5]. In the region of Tauranga in New Zealand during the
year of 2003, an incidence of 70 per 100 000 inhabitants,
even higher than the Australian statistics, was reported [6].
One explanation would be that the incidence of CM is also
strongly correlated with the latitude of the region, being
higher in areas of high solar radiation [5, 7].
Studies related to the incidence of melanoma in Brazil
are still scarce. According to the Brazilian National Cancer
Institute (INCA), the national incidence rate estimated for
2012 is low: 3170 new cases in men and 3060 new cases
in women. The highest estimated rates are in the south.
However, due to population characteristics and geographic
localization, the incidence of CM in southern Brazil is
possibly higher than estimated [8]. Geographically, Australia
and New Zealand (Queensland—26◦ to 29◦S) and southern
Brazil (western Santa Catarina—26◦ to 27◦S) are at similar
latitudes [9, 10].
In Brazil, compulsory notiﬁcation of cancer cases is
not yet a reality nationwide, occurring in only 30% of the
country. For this reason, the existence of a considerable
number of subrecords is possible [8].
The present study aimed to delineate the epidemiological
proﬁle of patients with CM treated in the western region of
the state of Santa Catarina, Brazil.2 Journal of Skin Cancer
Table 1: Number of cases per year and incidence of cutaneous melanoma in the west of Santa Catarina, Brazil (n = 497).
Year Number of cases of CM Western region population
∗ Incidence of CM (cases/100.000 inhabitants)
2002 50 678 428 7.4
2003 55 680 118 8.1
2004 51 681 796 7.5
2005 60 685 586 8,7
2006 64 687 586 9.3
2007 60 689 568 8,7
2008 89 727 014 12.2
2009 68 731 679 9.3
∗Calculation based on data from the Brazilian Institute of Geography and Statistics (2002–2009).
2.MaterialsandMethods
A cross-sectional study was performed combining research
during the period from 2002 to 2009, with longitudinal
research during the year 2009. The study was reviewed and
approved by the Ethics Research Committee of Unochapec´ o,
Santa Catarina, Brazil. Data were collected from the regional
cancer notiﬁcation service and from medical records of the
referral service for cancer treatment, using as reference the
modiﬁed protocol of the Brazilian Melanoma Group [11].
The incomplete data were ﬁlled in by contacting patients,
family, physicians, and health services by telephone. All
records pertaining to the western region of Santa Catarina
(Figure 1) with an initial diagnosis of CM were included
in this study and excluded those with ocular melanoma,
mucosal melanoma, and visceral melanoma. Demographic
data were extracted from the healthcare database of the
Brazilian government (DATASUS) [12]. Statistical analysis
was performed using the software SPSS Statistics version
19.0. For comparison of continuous variables, the Student’s
t-test was used, while the Chi-square and Fisher’s test were
used for nominal variables.
3. Results
3.1. Epidemiology of CM in the Western Region of Santa
Catarina. Ineightyears,503caseswereregistered,but6were
excluded from the study due to lack of data. The number of
CM cases per year in the region ranged from 50 in 2002 up
to 89 in 2008, resulting in an incidence of 7.4 and 12.2 per
100 000 inhabitants, respectively. The prevalence of CM in
the region over a period of eight years was 71.5 cases per 100
000 inhabitants, and the incidence in 2009 was 9.3 cases per
100 000 inhabitants (Table 1).
Patients were from 78 diﬀerent counties. Most were
originally from Chapec´ o (26.2%) followed by S˜ ao Miguel
do Oeste (5.2%). The county with the highest prevalence of
CM during this period was S˜ ao Jo˜ ao do Oeste, with 305.6
cases per 100 000 inhabitants. The county of the greatest
incidence of CM in 2009 was Nova Itaberaba, with 71.1 cases
per 100,000.
As shown in Figure 2, a higher CM prevalence was found
among individuals older than 50 years, with the highest rate
being found among those aged 80 years or more. However,
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Figure 1: Cumulative frequency distribution of age-speciﬁc rates
for cutaneous melanoma in the western region of Santa Catarina,
Brazil, by gender from 2002 to 2009 (xy men and xy women).
this age group represents the minority of patients in the
region.
3.2. Clinical Characteristics of Patients. The average patient
age was 50.6 years (SD = 15.4 years), with ages ranging from
14 to 90 years. Most patients were in the economically active
age group (20 to 50 years), which accounted for 50.7% of
individuals.
We found that the disease is more prevalent among
women (292 cases) than among men (205 cases) (P<0.01).
The incidence in 2009 was 10.21 per 100 000 women and 8.5
per 100 000 men, while the prevalence over a period of eight
yearswas84.2per100000womenand58.8per100000men.Journal of Skin Cancer 3
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Figure 2:WesternregionofthestateofSantaCatarina,Brazil,from
the Brazilian Institute of Geography and Statistics, 2010.
The average age among females was 50.8 years (SD = 15.6)
and 50.4 years for males (SD = 15.2) (Figure 2).
A total of 445 (92.7%) patients were skin types I and
II. A total of 237 (52.5%) had light hair and 247 (54.8%)
had light-colored eyes (green or blue). Other characteristics
evaluated were the history of ephelides in childhood, which
was positive in 166 cases. Occupational sun exposure was
considered high in 327 cases. Thirty-eight patients had
a history of sunburn during childhood and 73 during
adulthood. A total of 167 presented sunburn history in
both childhood and adulthood; 164 presented no history
of sunburn. The presence of congenital nevus related to
melanoma was positive in 84 cases. One hundred forty-three
patients presented multiple nevi. Of these, only 51 presented
more than 50 nevi. The presence of atypical nevi detected by
histopathological examination occurred in 43 cases.
Men showed a predominance of CM occurring on the
head,neck,andtrunkareas(58.9%)andwomenonthelimbs
(59.8%) (Figures 3, 4 and Table 2).
3.3. Histopathological Characteristics of Patients. The skin
lesions presented by the patients underwent histopathologi-
cal evaluation by specialized laboratories which followed the
standards recommended by the Brazilian Melanoma Group
(BMG). Regarding the size (area in mm2) of the primary
lesion, there was a variation between 1.04 and 9.090 with an
averageof 419.9 (SD =972.8). Thelesions of25patients were
not measured, and 28 had metastatic disease of unknown
primary site at the time of diagnosis.
We found that the most common histological type was
superﬁcial spreading CM (SSM) with 287 cases (59.92%),
followed by nodular CM (NM) with 90 cases (18.79%),
lentigo maligna CM (LMM) with 33 (8.89%), acral lentigi-
nous (ALM) with 17 (3.55%), and desmoplastic (DM) in 3
cases (0.63%).
Figure 3: Anatomical sites of cutaneous melanoma lesions in male
patients in the western region of Santa Catarina, Brazil, from 2002
to 2009 (n = 205). ∗Patients with metastatic cutaneous melanoma
for lymph nodes and unknown primary cutaneous site on ﬁrst
presentation.
Figure 4: Anatomical sites of cutaneous melanoma lesions in
women patients in western region of Santa Catarina, Brazil, from
2002 to 2009 (n = 292). ∗Patients with metastatic CM for lymph
nodes and unknown primary cutaneous site on ﬁrst presentation.
When considering the sex of the patients, diﬀerences
were observed in relation to the variability in pathological
staging. Cutaneous lesions, classiﬁed as pTis, pT1, and pT2,
were more common in females when compared to males
(P = 0.01). Ulcerations were more common among men
(41.6%) than among women (30.3%) (P = 0.01).4 Journal of Skin Cancer
Table 2: Clinical and histopathological characteristics of patients with cutaneous melanoma in the western region of Santa Catarina, Brazil,
classiﬁed by gender.
Characteristics (n)M e n W o m e n P
Age (497) 50.45 ±15.20 50.81 ±15.57 0.045∗∗
Site (489) <0.001∗
Head and neck 36 (17.82) 55 (19.16)
Trunk 73 (36.14) 55 (19.16)
Members 76 (37.62) 164 (57.14)
Unknown 17 (8.42) 13 (4.54)
Histological type (445) 0.04
∗
SSM 104 (59.10) 183 (68.03)
NM 42 (23.86) 48 (17.84)
LMM 13 (7.39) 20 (7.43)
MAL 8 (4.54) 9 (3.35)
Other 9 (5.11) 9 (3.35)
Tumor thickness (mm) (462) <0.01∗
≤1 mm 73 (39.46) 135 (48.74)
1.01–2.0 29 (15.67) 54 (19.49)
2.01–4.0 28 (15.14) 49 (17.69)
>4.0 55 (29.73) 39 (14.08)
Clark (420) <0.01∗
I 26 (15.76) 29 (11.37)
II 16 (9.70) 42 (16.47)
III 33 (20) 78 (30.59)
IV 72 (43.64) 100 (39.22)
V 18 (10.90) 6 (2.35)
Presence of ulceration (418) 0.013
∗
Yes 67 (41.61) 78 (30.35)
No 94 (58.39) 179 (69.65)
Presence of regression (399) 0.254
∗
Yes 37 (24.02) 49 (20.00)
No 117 (75.98) 196 (80.00)
Mitotic index (mitoses/mm2) (401) 0.045
∗
0 27 (17.65) 49 (19.76)
≥1 126 (82.35) 199 (80.24)
SLN positive (225) 0.600
∗
Yes 21 (24.70) 16 (11.42)
No 64 (72.30) 124 (88.57)
Growth phase (434) 0.271
∗
Radial 28 (16.57) 49 (18.49)
Vertical 141 (83.43) 216 (81.51)
Vascular invasion (400) 0.877
∗
Yes 16 (10.19) 24 (9.88)
No 141 (89.81) 219 (90.12)
Perineural invasion (392) 0.398
∗
Yes 6 (3.82) 4 (1.70)
No 151 (96.18) 231 (98.30)
Datapresentedasmean ±SDandfrequency(percentage). ∗∗Student’st-test ∗Chi-squaretest.SSM,superﬁcialspreadingmelanoma;NM,nodularmelanoma;
LMM, lentigo maligna melanoma; MAL, acrolentiginous melanoma; SLN, sentinel lymph node.Journal of Skin Cancer 5
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(SD = 5.04). Considering the invasion of adjacent structures,
vascular or lymphatic invasion was observed in 40 patients
and perineural invasion was present in 10 patients. Peritu-
moral inﬂammatory inﬁltrate appeared in 287 lesions and
intratumoral in 222.
Of the 45.3% of patients who were submitted to sentinel
lymph node research, 16.4% were SLN positive and under-
went radical lymphadenectomy. Of these, 14.5% showed
other lymph node metastases. In addition to SLN-positive
patients,72alsounderwentradicallymphadenectomydueto
clinically compromised lymph nodes (Table 2).
Upon clinical staging at the moment of diagnosis (n =
464), it was found that most patients analyzed (39.4%) were
in stage I. A total of 102 individuals (21.9%) were in stage
II, 72 (15.5%) were in stage III, and 52 (11.2%) already had
advanced disease and were classiﬁed as stage IV.
4. Discussion
4.1. Epidemiology. Studies have reported a sharp increase
in incidence and mortality of CM among the Caucasian
populationinthelastcentury,whichrepresentsanimportant
public health problem [4, 13–15]. The ﬁrst step towards
developing strategies for disease prevention is to evaluate
the magnitude of the problem and the characteristics of the
aﬀected population [13].
To standardize the epidemiological data related to
melanoma, in 2004 the BMG established the Registro
Brasileiro de Melanoma (Brazilian Melanoma Registry)
which enables complete clinical assessment of patients and
subsequent dissemination of national data [11].
The city of Chapec´ o is the oﬃcial registration center of
CM cases in the western region of Santa Catarina for the
treatment of this malignancy. A previous study assessing the
western region of Santa Catarina, carried out by Moreno
(2005) in the period between 2002 and 2005, reported an
average incidence of 14.5 cases per 100 000 inhabitants (data
not published). In this study, the prevalence of CM in the
region,overaperiodofeightyears,was71.5casesper100000
inhabitants and in 2009 the incidence was 9.3 cases per 100
000 inhabitants. The town of Nova Itaberaba had the highest
incidence rate, 71.1 cases per 100 000 inhabitants. These data
demonstratethattheoccurrenceofthisdisease,inthisregion
of Brazil, is much higher than national and global levels.
4.2. Geographic Location. In 1956, Lancaster suggested that
the geographical distribution of mortality from CM was
related to increased sun exposure in areas with low latitude,
such as New Zealand and Australia, which have the highest
r a t e so fC Mi nt h ew o r l d[ 16, 17]. More recently, another
study conducted in Europe reaﬃrmed the hypothesis that
locations closer to the equator are associated to higher
incidence rates of CM [18].
Brazil, the largest country in South America and the
world’s ﬁfth largest country by geographical area, is located
between latitudes 5◦Na n d3 4 ◦S. Due to this characteris-
tic, diﬀerent climates exist throughout the country [10].
A recent work failed to characterize the existence of seasonal
variabilityofCMinthestateofRioGrandedoSul,butfound
an incidence well above that seen in the rest of the country,
suggesting that this is mainly due to low latitude [19]. The
state of Santa Catarina is located between parallel 25◦ and
29◦S, similar to the Australia and New Zealand location (10◦
and 39◦S) [9, 10]. This could be an explanation for the
high rates of CM in the region, added to the fact that the
population is composed mostly of Caucasians.
4.3. UV Radiation and Ethnicity. After 50 years of epidemi-
ological research, Eide and Weinstock [2] found that there is
a low incidence of CM among Hispanics, Asians, and blacks.
This has been attributed to the protective eﬀect of skin with
dark pigmentation [2]. An American study, which evaluated
data from 11 centers for cancer registries over a period of
10 years, pointed to UV radiation as a key risk factor in the
etiology of CM, especially in individuals with skin types I
and II [20]. The population of western Santa Catarina has
a higher risk of CM since it is an area colonized primarily
by Caucasians. In this study we found that 99.6% of patients
were white and, among them, 92.7% had skin types I and II.
The presence of ephelides was observed in 38% of subjects,
showing poor solar tolerance [2, 21].
Sun exposure, an important risk factor for developing
CM, is even more damaging when it occurs in childhood in
an intense and intermittent way [1, 22]. Many of the patients
analyzed in this work presented the following risks: 66.6%
worked in places of high sun exposure and 54.1% had a
history of sunburn during childhood.
Besides the fact that the incidence of UV radiation
increases by 7% during the summer in the southern hemi-
sphere, if compared to the northern hemisphere [23], the
southern region presents a smaller thickness of the ozone
layer along with a lower amount of dust and pollutants than
the northern hemisphere, which facilitates the penetration
of UV rays [23] According to statistics from the National
Institute for Space Research (INPE), the incidence of UV on
a typical summer day varied between 8 and 12 in western
SantaCatarina. This levelofradiation is veryhighforhuman
populations, requiring extreme protective measures [24].
4.4. Gender and Age. In agreement with previous studies
[25, 26], we observed a higher incidence of CM in women
(58.75%). The average age of CM patients in the western
region of Santa Catarina was approximately 50 years, similar
to that reported in a study performed with 365 patients
diagnosed with CM in the city of S˜ ao Paulo, Brazil, from
May 1993 to January 2006 [14]. Nevertheless, in support
of ﬁndings that demonstrate an increase in prevalence and
incidence of CM with age, particularly after age 50 [27],
we found the highest prevalence of the disease among
individuals older than 50 years.
Gender is also considered a prognostic factor for cuta-
neous melanoma [28]. In a study conducted in Canada
during the period from 1956 to 2005, there was a signiﬁcant
variation in the location of the primary lesion according
to gender [28] .M e nt e n dt oh a v et u m o r si nt h ea x i a l6 Journal of Skin Cancer
region, which are more likely to develop metastatic lesions
[25, 29]. In our study, women presented more lesions on
limbs (59.8%), while men presented lesions on the head,
neck, and torso (58.9%).
4.5. Nevi. Several studies claim that the presence of atypical,
multiplemelanocyticorcongenitalneviisstronglycorrelated
to the emergence of CM. A frequency of clinically atypical
nevi in patients with a history of CM, ranging from 34
to 59%, has been previously reported [30]. Data from this
study showed that 9.7% of patients had atypical nevi, a
much lower incidence than expected, which may be due to
underdiagnosis.
There is still much controversy regarding the classiﬁ-
cation and risk of development of CM from congenital
melanocytic nevi [31]. In this study, the likelihood of
developing CM from a congenital nevus could not be
assessed, but we found that 18.7% of patients had congenital
nevi, and of these, 2.4% were giant, 36.9% medium, and
60.7% small.
Several studies have shown an association of multiple
melanocytic nevi (especially above 50 nevi) with the devel-
opment of CM [32]. In the present study, 11.4% of patients
presented more and 20.7% presented less than 50 nevi, and
therefore it was not possible to correlate the presence of
multiple nevi with the risk of developing CM.
4.6. Histopathological Characteristics. In an investigation of
clinical and histological factors associated with melanoma
thickness conducted in New Zealand with 14 646 patients
diagnosed in the period between 1996 and 2006, 48.1% of
the patients showed SSM and 11.5% had NM [33]. Similarly,
in this study, of 479 patients with CM, the most common
type was SSM with 287 cases (59.9%), followed by NM with
90 (18.8%).
According to a recent work conducted in Australia,
which evaluated 912 patients with primary CM diagnosed
in a period of two years, tumor thickness, as described by
Breslow, has proven to be the best reproducible prognostic
factor. In contrast, Clark’s level has shown low levels of
interobserver agreement. The majority of patients presented
Clark III and IV [34]. These results were similar to those
found in western Santa Catarina, where most of the lesions
(40.95%) were in Clark level IV and 26.43% in level III.
4.7. Sentinel Lymph Node. We found that in the western
region of Santa Catarina, 16.4% of patients tested for SLN
were positive. Similar data were obtained in a previous study
in which 1327 patients with primary CM of intermediate
thickness (1.2 to 3.5mm) were followed from 1994 to 2002.
Ofthese,764weretestedforSLNand16%werepositive[35].
In the United States, the American Joint Committee
on Cancer recommended complete lymphadenectomy as
standard therapy for patients in stage III CM [36]. A study
that evaluated 2203 patients, from 1999 to 2003, who were
submitted to SLN biopsy and were SLN positive, showed that
only 14% of patients who underwent lymphadenectomy had
no positive sentinel lymph node [37]. The ﬁndings of this
study are similar to the American data as only 14.5% of this
group of patients had negative sentinel lymph nodes.
4.8. Stage. Several American and European studies have
shown that the diagnosis of CM occurs mainly in early stages
[38–40]. The analysis of all cases of CM diagnosed in the
United States between 1985 and 1994, obtained from the
National Cancer Data Base, showed that 62.6% of them were
in stages 0 and I at diagnosis [41].
In developing countries, the diagnosis of CM usually
occurs at later stages. In Brazil, several studies have demon-
strated that approximately 50% of patients were classiﬁed as
stages IV and V at the moment of diagnosis [42–44]. Our
results diﬀer from national data, since similarly to developed
countries, 61.3% of the patients were in stages 0–II.
5. Conclusions
The incidence and prevalence of CM found in the western
region of Santa Catarina are much higher than those
found elsewhere in the country and are above the estimates
proposed by the INCA. This fact is most likely due to
the phenotypic characteristics of the population, which is
composed mostly of descendants of Europeans with skin
phototypes I and II. It can also be correlated to the life
habitsoftheindividualsfromthisregion,suchascontinuous
or intermittent sun exposure without the use of sunscreen
causing burns, especially in childhood. Another hypothesis
is that there is a high incidence of UV radiation in this region
due to its location in southern Brazil, as is the case in the
countries of Oceania, which have high UV radiation and the
highestincidenceofCM.TheaverageageofCM patients was
50 years, but, considering the prevalence according to age,
an increased rate of CM after the age 50 was observed. CM
was more common among women. However, unfavorable
prognostic factors were more related to men as well as the
largest number of ulcerated lesions and the greater depth of
dermal invasion. The most common histological subtypes in
order of occurrence were SSM, NM, and LMM. Most lesions
showedtumorthicknessindicesbetween1and2mm,Clark’s
levels between III and IV, and a mitotic index of ≥1/mm2.I n
most cases, the disease was at an early stage (0, I, or II) at the
moment of diagnosis.
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